Llwytho...
ACS Chemical Neuroscience Molecule Spotlight on Fanapt
[Image: see text] The new mixed dopamaine D(2)/serotonin 5-HT(2A) antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Chemical Society
2010
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368683/ https://ncbi.nlm.nih.gov/pubmed/22778835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn100024g |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|